https://orcid.org/0000-0003-0707-7441
References
- Hornung T, Ko A, Tüting T, Bieber T, Wenzel J. Efficacy of low-dose methotrexate in the treatment of dermatomyositis skin lesions. Clin Exp Dermatol. 2012;37(2):139–142. doi:10.1111/j.1365-2230.2011.04188.x
- Perna DL, Callen JP, Schadt CR. Association of treatment with secukinumab with exacerbation of dermatomyositis in a patient with psoriasis. JAMA Dermatol. 2022;158(4):454–456. doi:10.1001/jamadermatol.2021.6011
- Schreiber C, Khamlong M, Raza N, Huynh BQ. Overlap of psoriatic arthritis and dermatomyositis. J Investig Med High Impact Case Rep. 2021;9:23247096211057702. doi:10.1177/23247096211057702
- Xing Y, Xie J, Jiang S, Upasana M, Song J. Co-existence of Juvenile dermatomyositis and psoriasis vulgaris with fungal infection: a case report and literature review. J Cosmet Dermatol. 2019;18(5):1560–1563. doi:10.1111/jocd.12869
- Kato Y, Yamamoto T. Development of psoriasis with relapse of dermatomyositis-associated interstitial lung disease. Int J Rheum Dis. 2017;20(5):660–661. doi:10.1111/1756-185X.13084
- Montoya CL, Gonzalez ML, Ospina FE, et al. Case of amyopathic juvenile dermatomyositis associated with psoriasis successfully treated with ustekinumab. J Clin Rheumatol. 2017;23(2):129–130. doi:10.1097/RHU.0000000000000430
- Inkeles MS, No D, Wu JJ. Clinical improvement of a patient with both amyopathic dermatomyositis and psoriasis following treatment with cyclosporine. Dermatol Online J. 2017;23(8). doi:10.5070/D3238036019
- Akiyama M, Ueno T, Kanzaki A, Kuwana M, Nagao M, Saeki H. Association of psoriasis with Hashimoto’s thyroiditis, Sjögren’s syndrome and dermatomyositis. J Dermatol. 2016;43(6):711–712. doi:10.1111/1346-8138.13265
- Dicaro D, Bowen C, Dalton SR. Dermatomyositis associated with anti-tumor necrosis factor therapy in a patient with psoriasis. J Am Acad Dermatol. 2014;70(3):e64–5. doi:10.1016/j.jaad.2013.11.012
- Kim HJ, Choi EW, Choi EJ, et al. Non-thermal plasma promotes hair growth by improving the inter-follicular macroenvironment. RSC Adv. 2021;11(45):27880–27896.
- Machado NP, Camargo CZ, Oliveira AC, Buosi AL, Pucinelli ML, Souza AW. Association of anti-glomerular basement membrane antibody disease with dermatomyositis and psoriasis: case report. Sao Paulo Med J. 2010;128(5):306–308. doi:10.1590/S1516-31802010000500012
- Gran JT, Gunnarsson R, Mørk NJ. En mann med erytrodermi, muskelsvakhet og vekttap [A man with erythrodermia, muscle weakness and weight loss]. Tidsskr nor Laegeforen. 2009;129(21):2240–2241. Norwegian. doi:10.4045/tidsskr.09.0184
- Pavlović MD, Zecević RD, Zolotarevski L. Psoriasis in a patient with dermatomyositis. Vojnosanit Pregl. 2004;61(5):557–559. doi:10.2298/VSP0405557P
- Liu J, Chang HW, Grewal R, et al. Transcriptomic profiling of plaque psoriasis and cutaneous T-cell subsets during treatment with secukinumab. JID Innovations. 2022;2(3):100094. doi:10.1016/j.xjidi.2021.100094
- Cassius C, Amode R, Delord M, et al. MDA5(+) dermatomyositis is associated with stronger skin type I interferon transcriptomic signature with upregulation of IFN-κ transcript. J Invest Dermatol. 2020;140(6):1276–1279.e7. doi:10.1016/j.jid.2019.10.020
- Dillon KL. A comprehensive literature review of JAK inhibitors in treatment of alopecia areata. Clin Cosmet Investig Dermatol. 2021;14:691–714. doi:10.2147/CCID.S309215
- Appeldoorn TYJ, Munnink THO, Morsink LM, Hooge MNL, Touw DJ. Pharmacokinetics and pharmacodynamics of ruxolitinib: a review. Clin Pharmacokinet. 2023;62:559–571. doi:10.1007/s40262-023-01225-7
- Fougerousse AC, Jacobzone C, Mery-Bossard L, et al. Use of systemic medications for treating adult atopic dermatitis in France: results of a practice survey. Clin Cosmet Investig Dermatol. 2021;14:179–183. doi:10.2147/CCID.S300402